Des-(2-butyl) N-Allyl Itraconazole-D5
Stock Status: Enquire
Live
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
CAT No. CS-T-101565
Research Use
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Des-(2-butyl) N-Allyl Itraconazole-D5 Product Information
Des-(2-butyl) N-Allyl Itraconazole-D5 is listed under Stable Isotopes. It is associated with and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-101565.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Des-(2-butyl) N-Allyl Itraconazole-D5
CAS No.
-
CAT No.
CS-T-101565
Molecular Formula
C34H29D5Cl2N8O4
Molecular Weight
694.62
Category
Storage Condition
Refer MSDS for complete information.
IUPAC Name
Des-(2-butyl) N-Allyl Itraconazole-D5
Hazard Compound
Refer MSDS for complete information.
Description
Overview
"Des-(2-butyl) N-Allyl Itraconazole-D5 is the deuterium labelled analogue of Des-(2-butyl) N-Allyl Itraconazole (D297563), which is a compound with fungicidal activity. Des-(2-butyl) N-Allyl Itraconazole is related to Itraconazole (I937500), which is an orally active antimycotic structurally related to Ketoconazole. It is a COVID19-related research product."
Synonyms
"cis-4-[4-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(2-propenyl)-3H-1,2,4-triazol-3-one-D5;"
Application Notes
"Des-(2-butyl) N-Allyl Itraconazole-D5 is the deuterium labelled analogue of Des-(2-butyl) N-Allyl Itraconazole (D297563), which is a compound with fungicidal activity. Des-(2-butyl) N-Allyl Itraconazole is related to Itraconazole (I937500), which is an orally active antimycotic structurally related to Ketoconazole. It is a COVID19-related research product."
References
"Espinel-Ingroff, A., et al.: Antimicrob. Agents Chemother., 26, 5 (1984); Heeres, J., et al.: J. Med. Chem., 27, 894 (1984); Heykants, J., et al.: Mycoses, 32, Suppl 1, 67 (1989); Sugar, A.M.,et al.: Curr. Clin. Top. Infect. Dis., 13, 74 (1993);"
